VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q40130946  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000310.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q40130946‏
024 ‎‡a  0000-0001-9385-7393‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q40130946‏
100 0 ‎‡a  Yang Wang‏ ‎‡9  ast‏ ‎‡9  it‏ ‎‡9  es‏ ‎‡9  sl‏
400 0 ‎‡a  Yang Wang‏ ‎‡c  researcher (ORCID 0000-0001-9385-7393)‏ ‎‡9  en‏
670 ‎‡a  Author's A complex network of factors with overlapping affinities represses splicing through intronic elements‏
670 ‎‡a  Author's Adaptively Weighted and Robust Mathematical Programming for the Discovery of Driver Gene Sets in Cancers‏
670 ‎‡a  Author's An extensive program of periodic alternative splicing linked to cell cycle progression‏
670 ‎‡a  Author's Ancient diets indicate significant uplift of southern Tibet after ca. 7 Ma‏
670 ‎‡a  Author's Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo‏
670 ‎‡a  Author's BRCA1 regulates caveolin-1 expression and inhibits cell invasiveness‏
670 ‎‡a  Author's Cell cycle-dependent expression of centrosomal ninein-like protein in human cells is regulated by the anaphase-promoting complex.‏
670 ‎‡a  Author's Centrosomal Nlp is an oncogenic protein that is gene-amplified in human tumors and causes spontaneous tumorigenesis in transgenic mice‏
670 ‎‡a  Author's Extensive translation of circular RNAs driven by N6-methyladenosine‏
670 ‎‡a  Author's Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation‏
670 ‎‡a  Author's Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules‏
670 ‎‡a  Author's Modulation of alternative splicing induced by paclitaxel in human lung cancer.‏
670 ‎‡a  Author's The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer‏
670 ‎‡a  Author's Therapeutic effect of arsenic trioxide (As2O3) on cervical cancer in vitro and in vivo through apoptosis induction.‏
909 ‎‡a  (orcid) 0000000193857393‏ ‎‡9  1‏
919 ‎‡a  deubiquitylaseusp2maintainserbb2abundanceviacounteractingendocyticdegradationandrepresentsatherapeutictargetinerbb2positivebreastcancer‏ ‎‡A  The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer‏ ‎‡9  1‏
919 ‎‡a  therapeuticeffectofarsenictrioxideas2o3oncervicalcancerinvitroandinvivothroughapoptosisinduction‏ ‎‡A  Therapeutic effect of arsenic trioxide (As2O3) on cervical cancer in vitro and in vivo through apoptosis induction.‏ ‎‡9  1‏
919 ‎‡a  centrosomalnlpisanoncogenicproteinthatisgeneamplifiedinhumantumorsandcausesspontaneoustumorigenesisintransgenicmice‏ ‎‡A  Centrosomal Nlp is an oncogenic protein that is gene-amplified in human tumors and causes spontaneous tumorigenesis in transgenic mice‏ ‎‡9  1‏
919 ‎‡a  cellcycledependentexpressionofcentrosomalnineinlikeproteininhumancellsisregulatedbytheanaphasepromotingcomplex‏ ‎‡A  Cell cycle-dependent expression of centrosomal ninein-like protein in human cells is regulated by the anaphase-promoting complex.‏ ‎‡9  1‏
919 ‎‡a  brca1regulatescaveolin1expressionandinhibitscellinvasiveness‏ ‎‡A  BRCA1 regulates caveolin-1 expression and inhibits cell invasiveness‏ ‎‡9  1‏
919 ‎‡a  arsenictrioxideas2o3reducestheinvasiveandmetastaticpropertiesofcervicalcancercellsinvitroandinvivo‏ ‎‡A  Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo‏ ‎‡9  1‏
919 ‎‡a  ancientdietsindicatesignificantupliftofsoutherntibetafterca7ma‏ ‎‡A  Ancient diets indicate significant uplift of southern Tibet after ca. 7 Ma‏ ‎‡9  1‏
919 ‎‡a  extensiveprogramofperiodicalternativesplicinglinkedtocellcycleprogression‏ ‎‡A  An extensive program of periodic alternative splicing linked to cell cycle progression‏ ‎‡9  1‏
919 ‎‡a  adaptivelyweightedandrobustmathematicalprogrammingforthediscoveryofdrivergenesetsincancers‏ ‎‡A  Adaptively Weighted and Robust Mathematical Programming for the Discovery of Driver Gene Sets in Cancers‏ ‎‡9  1‏
919 ‎‡a  complexnetworkoffactorswithoverlappingaffinitiesrepressessplicingthroughintronicelements‏ ‎‡A  A complex network of factors with overlapping affinities represses splicing through intronic elements‏ ‎‡9  1‏
919 ‎‡a  extensivetranslationofcircularrnasdrivenbyn6methyladenosine‏ ‎‡A  Extensive translation of circular RNAs driven by N6-methyladenosine‏ ‎‡9  1‏
919 ‎‡a  integrativeanalysisrevealedthemolecularmechanismunderlyingrbm10mediatedsplicingregulation‏ ‎‡A  Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation‏ ‎‡9  1‏
919 ‎‡a  intronicsplicingenhancerscognatesplicingfactorsandcontextdependentregulationrules‏ ‎‡A  Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules‏ ‎‡9  1‏
919 ‎‡a  modulationofalternativesplicinginducedbypaclitaxelinhumanlungcancer‏ ‎‡A  Modulation of alternative splicing induced by paclitaxel in human lung cancer.‏ ‎‡9  1‏
996 ‎‡2  LC|nr 93005593
996 ‎‡2  ISNI|0000000374399424
996 ‎‡2  RERO|A000175164
996 ‎‡2  ISNI|0000000048690419
996 ‎‡2  LC|no 96004549
996 ‎‡2  DNB|1325550272
996 ‎‡2  DNB|1293281883
996 ‎‡2  SUDOC|197649793
996 ‎‡2  SUDOC|200242334
996 ‎‡2  ISNI|0000000039936261
996 ‎‡2  RERO|A000175168
996 ‎‡2  PLWABN|9810699370505606
996 ‎‡2  LC|n 89119931
996 ‎‡2  ISNI|0000000382154013
996 ‎‡2  CYT|AC000618006
996 ‎‡2  CYT|AC000259077
996 ‎‡2  PLWABN|9811769723105606
996 ‎‡2  ISNI|0000000064086465
996 ‎‡2  NII|DA03453996
996 ‎‡2  ISNI|0000000419504938
996 ‎‡2  LC|nr 91006479
996 ‎‡2  DNB|119901432X
996 ‎‡2  PLWABN|9811772643705606
996 ‎‡2  RERO|A022471671
996 ‎‡2  CYT|AC000208773
996 ‎‡2  ISNI|0000000044596636
996 ‎‡2  LC|nr 92024432
996 ‎‡2  DNB|1082352861
996 ‎‡2  CYT|AC000424303
996 ‎‡2  KRNLK|KAC200305298
996 ‎‡2  LC|n 88655967
996 ‎‡2  ISNI|0000000383147085
996 ‎‡2  NTA|128419490
996 ‎‡2  DNB|1263239447
996 ‎‡2  DNB|1306927129
996 ‎‡2  CYT|AC000208961
996 ‎‡2  ISNI|0000000067817681
996 ‎‡2  SUDOC|122895169
996 ‎‡2  SUDOC|254092489
996 ‎‡2  LC|n 88031425
996 ‎‡2  LC|nr2003019226
996 ‎‡2  ISNI|0000000118724769
996 ‎‡2  LC|n 79074230
996 ‎‡2  CYT|AC000259585
996 ‎‡2  CYT|AC000259584
996 ‎‡2  SZ|1259535304
996 ‎‡2  LC|n 91122821
996 ‎‡2  ISNI|0000000063803979
996 ‎‡2  LC|n 2023057669
996 ‎‡2  DNB|115862848X
996 ‎‡2  SUDOC|261122339
996 ‎‡2  LC|n 80165857
996 ‎‡2  ISNI|0000000063711097
996 ‎‡2  LC|n 2024042507
996 ‎‡2  LC|n 2010004711
996 ‎‡2  DNB|127129839
996 ‎‡2  LC|n 96061111
996 ‎‡2  BNF|15537696
996 ‎‡2  W2Z|1707991624519
996 ‎‡2  LC|n 2019022257
996 ‎‡2  CAOONL|ncf11701070
996 ‎‡2  CYT|AC000653455
996 ‎‡2  NUKAT|n 2016064576
996 ‎‡2  LIH|LNB:C30_i_;=BF
996 ‎‡2  DNB|1319275516
996 ‎‡2  ISNI|000000011483002X
996 ‎‡2  ISNI|0000000072688335
996 ‎‡2  CYT|AC000653596
996 ‎‡2  DNB|1246367033
996 ‎‡2  BNF|13741722
996 ‎‡2  LC|no2023033414
996 ‎‡2  ISNI|0000000493981273
996 ‎‡2  CYT|AC000639427
996 ‎‡2  PLWABN|9810590626205606
996 ‎‡2  DNB|1295769077
996 ‎‡2  DNB|129638117X
996 ‎‡2  ISNI|0000000051248656
996 ‎‡2  DNB|136032141
996 ‎‡2  DNB|1349659134
996 ‎‡2  NDL|00891034
996 ‎‡2  PLWABN|9812422896505606
996 ‎‡2  LC|no2006029710
996 ‎‡2  LC|no2007076514
996 ‎‡2  PLWABN|9810623830005606
996 ‎‡2  CYT|AC000642083
996 ‎‡2  LC|n 88218473
996 ‎‡2  DNB|1345110839
996 ‎‡2  SUDOC|176325719
996 ‎‡2  DNB|1213268974
996 ‎‡2  CYT|AC000208147
996 ‎‡2  CAOONL|ncf11905952
996 ‎‡2  LC|n 87932263
996 ‎‡2  DNB|105086039X
996 ‎‡2  CYT|AC000429161
996 ‎‡2  LC|n 2014052688
996 ‎‡2  LC|n 85275359
996 ‎‡2  LC|nr 99008876
996 ‎‡2  LC|nr 95005630
996 ‎‡2  ISNI|0000000063591435
996 ‎‡2  PLWABN|9810700645405606
996 ‎‡2  CYT|AC000642150
996 ‎‡2  CAOONL|ncf11934366
996 ‎‡2  ISNI|0000000050263803
996 ‎‡2  LC|n 81077176
996 ‎‡2  LC|n 2019051852
996 ‎‡2  DNB|1156279003
996 ‎‡2  CYT|AC000217957
996 ‎‡2  SUDOC|184302951
996 ‎‡2  LC|no2017068214
996 ‎‡2  SUDOC|272984671
996 ‎‡2  DNB|1144302137
996 ‎‡2  LC|nb2022013180
996 ‎‡2  CYT|AC000636631
996 ‎‡2  DNB|1226822312
996 ‎‡2  CYT|AC000493487
996 ‎‡2  CYT|AC000007546
996 ‎‡2  NUKAT|n 2016006108
996 ‎‡2  CYT|AC000046456
996 ‎‡2  ISNI|0000000454529524
996 ‎‡2  CYT|AC000099163
996 ‎‡2  DNB|1065181809
996 ‎‡2  NTA|181979667
996 ‎‡2  DNB|101303029X
996 ‎‡2  BNF|15067230
996 ‎‡2  ISNI|0000000382741402
996 ‎‡2  DNB|1262029538
996 ‎‡2  ISNI|0000000107188681
996 ‎‡2  CYT|AC000400491
996 ‎‡2  CYT|AC000400493
996 ‎‡2  DNB|1310757844
996 ‎‡2  BIBSYS|2075601
996 ‎‡2  NTA|364168250
996 ‎‡2  ISNI|0000000063553383
996 ‎‡2  CYT|AC000652495
996 ‎‡2  NKC|pna2006362718
996 ‎‡2  NTA|095885919
996 ‎‡2  LC|no2022132625
996 ‎‡2  LC|n 83047228
996 ‎‡2  CYT|AC000635618
996 ‎‡2  LC|no2022142256
996 ‎‡2  BNF|15111569
996 ‎‡2  DNB|1296592499
996 ‎‡2  ISNI|0000000108452077
996 ‎‡2  NSK|000461453
996 ‎‡2  DNB|1274341760
996 ‎‡2  CYT|AC000577822
996 ‎‡2  DNB|1104853744
996 ‎‡2  RERO|A003957531
996 ‎‡2  ISNI|0000000051083193
996 ‎‡2  LC|no2003023487
996 ‎‡2  CYT|AC000208926
996 ‎‡2  ISNI|0000000054751003
996 ‎‡2  ISNI|0000000053976251
996 ‎‡2  BIBSYS|97052751
996 ‎‡2  LC|ns2011000045
996 ‎‡2  ISNI|0000000083724485
996 ‎‡2  DNB|1046472542
996 ‎‡2  NTA|323258107
996 ‎‡2  CYT|AC000210306
996 ‎‡2  ISNI|0000000083347202
996 ‎‡2  CYT|AC000659360
996 ‎‡2  LNB|LNC10-000130656
996 ‎‡2  LC|no2016100551
996 ‎‡2  DNB|1237003016
996 ‎‡2  DNB|1141394197
996 ‎‡2  ISNI|0000000063272194
996 ‎‡2  CYT|AC000000182
996 ‎‡2  PLWABN|9810622444905606
996 ‎‡2  LC|n 2019005326
996 ‎‡2  SUDOC|259894982
996 ‎‡2  CYT|AC000260742
996 ‎‡2  DBC|87097969074782
996 ‎‡2  CAOONL|ncf10382461
996 ‎‡2  CAOONL|ncf10723261
996 ‎‡2  LC|n 81106490
996 ‎‡2  LC|n 83214563
996 ‎‡2  ISNI|0000000073579034
996 ‎‡2  ISNI|0000000444584167
996 ‎‡2  ISNI|0000000356962885
996 ‎‡2  CYT|AC000261843
996 ‎‡2  ISNI|0000000504288256
996 ‎‡2  CYT|AC000451516
996 ‎‡2  ISNI|0000000126262883
996 ‎‡2  LC|no2023132808
996 ‎‡2  SUDOC|235673439
996 ‎‡2  DNB|1197420614
996 ‎‡2  DNB|1072156938
996 ‎‡2  BNF|16274233
996 ‎‡2  ISNI|000000037789501X
996 ‎‡2  J9U|987007370953405171
996 ‎‡2  LC|no2015138325
996 ‎‡2  LC|no2002038662
996 ‎‡2  DNB|1231239352
996 ‎‡2  LC|nr 90011242
996 ‎‡2  CYT|AC000641535
996 ‎‡2  ISNI|0000000064262828
996 ‎‡2  NTA|438699432
996 ‎‡2  NDL|00346721
996 ‎‡2  PLWABN|9811552474005606
996 ‎‡2  DNB|1059125005
996 ‎‡2  DNB|123823609X
996 ‎‡2  DNB|1162524022
996 ‎‡2  SUDOC|250833409
996 ‎‡2  LC|no2015086068
996 ‎‡2  BIBSYS|8067012
996 ‎‡2  CYT|AC000259536
996 ‎‡2  SUDOC|194417719
996 ‎‡2  ISNI|0000000063126285
996 ‎‡2  ISNI|0000000104903096
996 ‎‡2  CYT|AC000540917
996 ‎‡2  CYT|AC000653085
996 ‎‡2  LC|n 83122292
996 ‎‡2  RERO|A027169319
996 ‎‡2  DNB|1338182404
996 ‎‡2  NSK|000545635
996 ‎‡2  LC|n 79147631
996 ‎‡2  NTA|387585427
996 ‎‡2  LC|n 91026181
996 ‎‡2  NTA|264440439
996 ‎‡2  LC|n 2016181547
996 ‎‡2  CAOONL|ncf10695737
996 ‎‡2  LC|nr 98036737
996 ‎‡2  DNB|1178378187
996 ‎‡2  NUKAT|n 2021123640
996 ‎‡2  DNB|1318496829
996 ‎‡2  ISNI|0000000029948875
996 ‎‡2  DNB|170718026
996 ‎‡2  J9U|987007346074605171
996 ‎‡2  LC|no2022106475
996 ‎‡2  SUDOC|030260310
996 ‎‡2  SUDOC|189620226
996 ‎‡2  LC|n 85352902
996 ‎‡2  NSK|000705227
996 ‎‡2  CYT|AC000208904
996 ‎‡2  PLWABN|9810596153905606
996 ‎‡2  CYT|AC000457327
996 ‎‡2  ISNI|0000000457685290
996 ‎‡2  DNB|1315050080
996 ‎‡2  LC|n 2013030029
996 ‎‡2  CAOONL|ncf11934459
996 ‎‡2  ISNI|0000000063799316
996 ‎‡2  CYT|AC000642431
996 ‎‡2  CYT|AC000639520
996 ‎‡2  CYT|AC000636169
996 ‎‡2  CYT|AC000642354
996 ‎‡2  DNB|1133094155
996 ‎‡2  NUKAT|n 2013143379
996 ‎‡2  CYT|AC000118449
996 ‎‡2  J9U|987007330657005171
996 ‎‡2  CYT|AC000259792
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏
998 ‎‡a  Yang, Wang‏ ‎‡2  NSK|000699920‏ ‎‡3  exact name‏
998 ‎‡a  王洋‏ ‎‡2  ISNI|0000000108908396‏ ‎‡3  exact name‏
998 ‎‡a  Yang, Wang‏ ‎‡2  ISNI|0000000108908396‏ ‎‡3  exact name‏
998 ‎‡a  Wang, Yang‏ ‎‡2  ISNI|0000000108908396‏ ‎‡3  exact name‏
998 ‎‡a  Yang, Wang‏ ‎‡2  SUDOC|196277361‏ ‎‡3  exact name‏
998 ‎‡a  Yang, Wang‏ ‎‡2  J9U|987007347137005171‏ ‎‡3  exact name‏
998 ‎‡a  Yang, Wang‏ ‎‡2  LC|nb 97041280‏ ‎‡3  exact name‏
998 ‎‡a  Yang, Wang.‏ ‎‡2  NUKAT|n 2006008658‏ ‎‡3  exact name‏